Startups
At aTENSION, we are redefining the future of hypertension care. It is our mission to make advanced mass spectrometry diagnostics accessible to everyone. Our ALDO+ testing platform sets new standards in precision diagnosis and personalized treatments enhancing the well-being and life quality of hypertensive patients. With just one blood sample it identifies underlying causes of uncontrolled hypertension and personalizes treatment therapies. ALDO+ is transforming hypertension diagnostics with unparalleled benefits for clinicians, labs and patients, delivering high diagnostic value, operational simplicity and cost efficacy.
Mentions in press and media 5
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| May 8, 2025 | aTENSION.life Raises USD 3M in Seed Funding | Dr. Werner Lanthaler aTENSION.life, a Vienna, Austria-based high-tech life science startup developing precision diagnostics for hypertension, raised USD 3m in seed financing. The round was led by Wlanholding, with participation from eQventu... |
| Apr 17, 2025 | The Pulse of Innovation: A Dive into the Startup Landscape | The startup ecosystem is a vibrant tapestry, woven with ambition, innovation, and a relentless pursuit of progress. In recent weeks, the pulse of this landscape has quickened, revealing trends that signal both challenges and opportunities. ... |
| Apr 14, 2025 | aTENSION.life sammelt 3 Millionen ein – CGC Genomics erhält 1,7 Millionen – Trove übernimmt reverse.supply | Im #DealMonitor für den 14. April werfen wir einen Blick auf die wichtigsten, spannendsten und interessantesten Investments und Exits des Tages in der DACH-Region. Alle Deals der Vortage gibt es im großen und übersichtlichen #DealMonitor-Ar... |
| aTension.life | “At aTENSION, we are redefining the future of hypertension care by setting new standards in precision diagnosis and personalized treatment.” |